Fredun Pharmaceuticals has installed a second Italian Tube Filling Machine at its production facility. This significant investment boosts the company’s production capacity by an impressive 2.9 times, enabling Fredun Pharmaceuticals to meet the growing demand for its high quality products.
The new state-of-the-art machine, manufactured by Axomatic in Italy, is a testament to Fredun’s commitment to technological advancement and operational efficiency. With this installation, the company is poised to meet the growing demand for its products, having recently received an order to manufacture 2 crores tubes. By FY26, Fredun is expected to produce 4 crore tubes, doubling its current capacity and solidifying its position in topical manufacturing. This strategic investment will ensure increased speed, precision, and automation, resulting in enhanced efficiency and reduced production time. It underscores Fredun's commitment to continuous improvement and its dedication to providing customers with timely and reliable product delivery.
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: